caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1174807838

Stephanie CordierN.P.

Nurse PractitionerRichmond, VAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Stephanie Cordier's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY25106
John Mccarty
Hematopoietic Cell Transplantation and Cellular Therapy · Richmond, VA
2185
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY34141
William Clark
Hematology-Oncology · Richmond, VA
2588
Harold Chung
Hematopoietic Cell Transplantation and Cellular Therapy · Richmond, VA
1856
John Mccarty
Hematopoietic Cell Transplantation and Cellular Therapy · Richmond, VA
1735
William Hall
Nurse Practitioner · Richmond, VA
1621
Roger Riley
Pathology · Richmond, VA
1233
Christine Fuller
Pathology · Cincinnati, OH
1115
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
106
Unique beneficiaries
—
Total services
134
Distinct HCPCS
2
Medicare payment
$6K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 5,426 Nurse Practitioner providers in VA — below median (cohort median 281).
QUALITY · MIPS · 2024
Final MIPS score
84.0
Quality
69.9
Cost
77.4
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.38%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
123
Beneficiaries
—
Total drug cost
$546K
Distinct drugs
7
Brand share
37.4%
Top prescribed drugs
Ruxolitinib Phosphate33 claims
Acyclovir20 claims
Atovaquone15 claims
Azithromycin15 claims
Prednisone14 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.